Carson City, Nevada–(Newsfile Corp. – May 7, 2018) – Cell MedX Corp. (OTCQB: CMXC), Cell MedX Corp. (“Cell MedX” or the “Company”), an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, announced today that, effective April 30, 2018, Dr. Terrance Owen resigned from his management and directorship positions with Cell MedX.
Name: Terrance Owen
Continent: North America
Company: Cell MedX Corp
Announcement Date: May 06, 2018, 10:00pm
Resignation Date: May 06, 2018, 10:00pm